Apr 19, 2024

Featuring perspectives from Dr Edward B Garon and Dr Corey J Langer, including the following topics.

• Role of Immune Checkpoint Inhibitors in Nonmetastatic Non-Small Cell Lung Cancer (NSCLC) — Dr Langer (0:00)
• Immune Checkpoint Inhibitors and Other Emerging Therapeutic Approaches for Metastatic NSCLC without...

Apr 19, 2024

Featuring perspectives from Dr Ibiayi Dagogo-Jack and Dr Henela Yu, including the following topics.

• Management of Non-Small Cell Lung Cancer (NSCLC) with an EGFR Mutation — Dr Yu (0:00)
• Care of Individuals with Other Targetable Genomic Abnormalities — Dr Dagogo-Jack (31:01)

CME information and select...

Mar 20, 2024

• Role of biomarker testing in optimal selection of first-line therapy for patients with non-small cell lung cancer (NSCLC) (0:00)
• Efficacy and safety with datopotamab deruxtecan for previously treated NSCLC (15:45)
• Antitumor activity with...

Dec 11, 2023

Featuring perspectives from Dr Luis Paz-Ares, Dr Zofia Piotrowska and Dr David R Spigel, including the following topics:

• Introduction (0:00)
• Localized Non-Small Cell Lung Cancer (NSCLC) (9:29)
• EGFR-Mutated Metastatic NSCLC (34:12)
• Other Targeted Treatment for Metastatic NSCLC (55:04)
• Updates on Immunotherapy in...

Dec 11, 2023

Implications of Recent Data Sets for the Current and Future Management of Lung Cancer | Faculty Presentation 3: Immunotherapeutic and Other Novel Strategies for Metastatic NSCLC and Small Cell Lung Cancer — Aaron Lisberg, MD  

CME information and select...